Related Experiment Video
Updated: Jan 15, 2026

05:33
Introduction of an Integrated Pathology Image Management, Artificial Intelligence, and Reporting System
Published on: July 11, 2025
800
Pathologist-like explainable AI for interpretable Gleason grading in prostate cancer.
Gesa Mittmann1,2, Sara Laiouar-Pedari1, Hendrik A Mehrtens1
1Division of Digital Prevention, Diagnostics and Therapy Guidance, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Nature Communications
|October 8, 2025
Summary
This study introduces an explainable AI for prostate cancer grading, improving Gleason score prediction accuracy. The AI uses pathologist-defined terms and soft labels for robust segmentation, aiding clinical decisions.
Area of Science:
- Digital pathology
- Artificial intelligence in medicine
- Computational pathology
Background:
- Prostate cancer aggressiveness is determined by the Gleason scoring system from histopathology.
- Current AI models for Gleason scoring lack explainability, hindering clinical adoption.
- High interobserver variability exists in Gleason scoring among pathologists.
Purpose of the Study:
- To develop an inherently explainable AI model for Gleason pattern segmentation in prostate cancer.
- To improve the robustness and interpretability of AI-driven histopathological analysis.
- To address the challenge of interobserver variability in medical image segmentation.
Main Methods:
- Trained an AI model on 1,015 prostate tissue microarray core images.
- Utilized detailed pattern descriptions annotated by 54 international pathologists.
- Employed pathologist-defined terminology and soft labels to manage data uncertainty.
Main Results:
- Achieved robust Gleason pattern segmentation comparable to direct segmentation methods (Dice score: 0.713 ± 0.003).
- The AI model provided interpretable outputs, enhancing clinical trust.
- Demonstrated superior performance in segmentation accuracy compared to conventional methods.
Conclusions:
- An inherently explainable AI approach can effectively segment Gleason patterns despite high interobserver variability.
- This method offers a promising alternative to conventional AI, enhancing clinical acceptance.
- The released dataset will foster research in subjective medical image segmentation and pathologist reasoning.

